Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8(+) T Cell Responses via CD169(+) Macrophages and cDC1

Podobne zapisy

• Optimization of Liposomes for Antigen Targeting to Splenic CD169(+) Macrophages
  od: Nijen Twilhaar, Maarten K., i wsp.
  Wydane: (2020)
• Selective tumor antigen vaccine delivery to human CD169(+) antigen-presenting cells using ganglioside-liposomes
  od: Affandi, Alsya J., i wsp.
  Wydane: (2020)
• Activation of CD8(+) T Cell Responses after Melanoma Antigen Targeting to CD169(+) Antigen Presenting Cells in Mice and Humans
  od: van Dinther, Dieke, i wsp.
  Wydane: (2019)
• Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma
  od: van Dinther, Dieke, i wsp.
  Wydane: (2018)
• CD169(+) Macrophages Capture and Dendritic Cells Instruct: The Interplay of the Gatekeeper and the General of the Immune System
  od: Grabowska, Joanna, i wsp.
  Wydane: (2018)